Heterogeneity of microRNAs expression in cervical cancer cells: Over-expression of miR-196a

International Journal of Clinical and Experimental Pathology

Volumn 7, Issue 4, 2014, Pages 1389-1401

  Villegas Ruiz, Vanessa ^a,e   Juárez Méndez, Sergio ^b   Pérez González, Oscar A ^b   Arreola, Hugo ^a   Paniagua García, Lucero ^a   Parra Melquiadez, Miriam ^a   Peralta Rodríguez, Raúl ^a   López Romero, Ricardo ^a   Monroy García, Alberto ^a   Mantilla Morales, Alejandra ^a   Gómez Gutiérrez, Guillermo ^c   Román Bassaure, Edgar ^d   Salcedo, Mauricio ^a  

^a HOSPITAL DE ONCOLOGÍA   (Mexico)

^b INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^c Clínica de Displasia Unidad de Oncología Hospital de México   (Mexico)

^d HOSPITAL GENERAL DE MÉXICO   (Mexico)

^e UNIVERSIDAD NACIONAL AUTÓNOMA DE MÉXICO   (Mexico)

Author keywords

Cervical cancer; HOXC8; MicroRNAs; miR 196a

Indexed keywords

HOMEODOMAIN PROTEIN; HOXC8 PROTEIN, HUMAN; MICRORNA; MIRN196 MICRORNA, HUMAN;

CELL LINE; FEMALE; GENE EXPRESSION REGULATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROARRAY ANALYSIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE; UPREGULATION; UTERINE CERVIX; UTERINE CERVIX TUMOR;

CELL LINE; CELL LINE, TUMOR; CERVIX UTERI; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROARRAY ANALYSIS; MICRORNAS; UP-REGULATION; UTERINE CERVICAL NEOPLASMS;

EID: 84899529653     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Article

References (49)

1. Gregory RI and Shiekhattar R. MicroRNA biogenesis and cancer. Cancer Res 2005; 65: 3509-3512.
2. Meltzer PS. Cancer genomics: small RNAs with big impacts. Nature 2005; 435: 745-746.
3. Mendell JT. MicroRNAs: critical regulators of development, cellular physiology and malignancy. Cell Cycle 2005; 4: 1179-1184.
4. Fabbri M, Croce CM and Calin GA. MicroRNAs. Cancer J 2008; 14: 1-6.
5. Lytle JR, Yario TA and Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5' UTR as in the 3' UTR. Proc Natl Acad Sci U S A 2007; 104: 9667-9672.
6. Ouellet DL, Perron MP, Gobeil LA, Plante P and Provost P. MicroRNAs in gene regulation: when the smallest governs it all. J Biomed Biotechnol 2006; 2006: 69616.
7. Calin GA and Croce CM. MicroRNA signatures in human cancers. Nat Rev Cancer 2006; 6: 857-866.
8. Esquela-Kerscher A and Slack FJ. Oncomirs-microRNAs with a role in cancer. Nat Rev Cancer 2006; 6: 259-269.
9. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, Peck D, Sweet-Cordero A, Ebert BL, Mak RH, Ferrando AA, Downing JR, Jacks T, Horvitz HR and Golub TR. MicroRNA expression profiles classify human cancers. Nature 2005; 435: 834-838.
10. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, Visone R, Iorio M, Roldo C, Ferracin M, Prueitt RL, Yanaihara N, Lanza G, Scarpa A, Vecchione A, Negrini M, Harris CC and Croce CM. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 2006; 103: 2257-2261.
11. World Health Organization. http://www.who.int/mediacentre/factsheets/fs380/en/.
12. Moody CA and Laimins LA. Human papillomavirus oncoproteins: pathways to transformation. Nat Rev Cancer 2010; 10: 550-560.
13. Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW and Wang X. A microRNA expression signature for cervical cancer prognosis. Cancer Res 2010; 70: 1441-1448.
14. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, Hwang SY, Kim WY, Kim TJ, Lee JH, Kim BG and Bae DS. Altered MicroRNA expression in cervical carcinomas. Clin Cancer Res 2008; 14: 2535-2542.
15. Lui WO, Pourmand N, Patterson BK and Fire A. Patterns of known and novel small RNAs in human cervical cancer. Cancer Res 2007; 67: 6031-6043.
16. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP and Khan SA. Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 2008; 27: 2575-2582.
17. Muralidhar B, Goldstein LD, Ng G, Winder DM, Palmer RD, Gooding EL, Barbosa-Morais NL, Mukherjee G, Thorne NP, Roberts I, Pett MR and Coleman N. Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels. J Pathol 2007; 212: 368-377.
18. Pereira PM, Marques JP, Soares AR, Carreto L and Santos MA. MicroRNA expression variability in human cervical tissues. PLoS One 2010; 5: e11780.
19. Wang X, Tang S, Le SY, Lu R, Rader JS, Meyers C and Zheng ZM. Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth. PLoS One 2008; 3: e2557.
20. Schmitt M, Dondog B, Waterboer T and Pawlita M. Homogeneous amplification of genital human alpha papillomaviruses by PCR using novel broad-spectrum GP5+ and GP6+ primers. J Clin Microbiol 2008; 46: 1050-1059.
21. Livak KJ and Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408.
22. Atfi A and Baron R. p53 brings a new twist to the Smad signaling network. Sci Signal 2008; 1: pe33.
23. Higareda-Almaraz JC, Enriquez-Gasca Mdel R, Hernandez-Ortiz M, Resendis-Antonio O and Encarnacion-Guevara S. Proteomic patterns of cervical cancer cell lines, a network perspective. BMC Syst Biol 2011; 5: 96.
24. Schoof CR, Botelho EL, Izzotti A and Vasques Ldos R. MicroRNAs in cancer treatment and prognosis. Am J Cancer Res 2012; 2: 414-433.
25. Ambs S, Prueitt RL, Yi M, Hudson RS, Howe TM, Petrocca F, Wallace TA, Liu CG, Volinia S, Calin GA, Yfantis HG, Stephens RM and Croce CM. Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. Cancer Res 2008; 68: 6162-6170.
26. Diosdado B, van de Wiel MA, Terhaar Sive Droste JS, Mongera S, Postma C, Meijerink WJ, Carvalho B and Meijer GA. MiR-17-92 cluster is associated with 13q gain and c-myc expression during colorectal adenoma to adenocarcinoma progression. Br J Cancer 2009; 101: 707-714.
27. Kim YK, Yu J, Han TS, Park SY, Namkoong B, Kim DH, Hur K, Yoo MW, Lee HJ, Yang HK and Kim VN. Functional links between clustered microRNAs: suppression of cell-cycle inhibitors by microRNA clusters in gastric cancer. Nucleic Acids Res 2009; 37: 1672-1681.
28. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, Sugihara K and Mori M. Over-and under-expressed microRNAs in human colorectal cancer. Int J Oncol 2009; 34: 1069-1075.
29. Pichiorri F, Suh SS, Ladetto M, Kuehl M, Palumbo T, Drandi D, Taccioli C, Zanesi N, Alder H, Hagan JP, Munker R, Volinia S, Boccadoro M, Garzon R, Palumbo A, Aqeilan RI and Croce CM. MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis. Proc Natl Acad Sci U S A 2008; 105: 12885-12890.
30. Jevnaker AM, Khuu C, Kjole E, Bryne M and Osmundsen H. Expression of members of the miRNA17-92 cluster during development and in carcinogenesis. J Cell Physiol 2011; 226: 2257-2266.
31. Li L, Shi JY, Zhu GQ and Shi B. MiR-17-92 cluster regulates cell proliferation and collagen synthesis by targeting TGFB pathway in mouse palatal mesenchymal cells. J Cell Biochem 2012; 113: 1235-1244.
32. Miko E, Czimmerer Z, Csanky E, Boros G, Buslig J, Dezso B and Scholtz B. Differentially expressed microRNAs in small cell lung cancer. Exp Lung Res 2009; 35: 646-664.
33. Xi Y, Formentini A, Chien M, Weir DB, Russo JJ, Ju J, Kornmann M and Ju J. Prognostic Values of microRNAs in Colorectal Cancer. Biomark Insights 2006; 2: 113-121.
34. Zhang Y, Li M, Wang H, Fisher WE, Lin PH, Yao Q and Chen C. Profiling of 95 microRNAs in pancreatic cancer cell lines and surgical specimens by real-time PCR analysis. World J Surg 2009; 33: 698-709.
35. Akao Y, Nakagawa Y and Naoe T. MicroRNAs 143 and 145 are possible common onco-microRNAs in human cancers. Oncol Rep 2006; 16: 845-850.
36. Takagi T, Iio A, Nakagawa Y, Naoe T, Tanigawa N and Akao Y. Decreased expression of microRNA-143 and-145 in human gastric cancers. Oncology 2009; 77: 12-21.
37. Wang CJ, Zhou ZG, Wang L, Yang L, Zhou B, Gu J, Chen HY and Sun XF. Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer. Dis Markers 2009; 26: 27-34.
38. Greco D, Kivi N, Qian K, Leivonen SK, Auvinen P and Auvinen E. Human papillomavirus 16 E5 modulates the expression of host microRNAs. PLoS One 2011; 6: e21646.
39. Braig S, Mueller DW, Rothhammer T and Bosserhoff AK. MicroRNA miR-196a is a central regulator of HOX-B7 and BMP4 expression in malignant melanoma. Cell Mol Life Sci 2010; 67: 3535-3548.
40. Luthra R, Singh RR, Luthra MG, Li YX, Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, Broaddus RR, Rashid A and Albar racin CT. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008; 27: 6667-6678.
41. Schimanski CC, Frerichs K, Rahman F, Berger M, Lang H, Galle PR, Moehler M and Gockel I. High miR-196a levels promote the oncogenic phenotype of colorectal cancer cells. World J Gastroenterol 2009; 15: 2089-2096.
42. Liu XH, Lu KH, Wang KM, Sun M, Zhang EB, Yang JS, Yin DD, Liu ZL, Zhou J, Liu ZJ, De W and Wang ZX. MicroRNA-196a promotes non-small cell lung cancer cell proliferation and invasion through targeting HOXA5. BMC Cancer 2012; 12: 348.
43. Li Y, Zhang M, Chen H, Dong Z, Ganapathy V, Thangaraju M and Huang S. Ratio of miR-196s to HOXC8 messenger RNA correlates with breast cancer cell migration and metastasis. Cancer Res 2010; 70: 7894-7904.
44. Mueller DW and Bosserhoff AK. MicroRNA miR-196a controls melanoma-associated ge-nes by regulating HOX-C8 expression. Int J Cancer 2011; 129: 1064-1074.
45. Adwan H, Zhivkova-Galunska M, Georges R, Eyol E, Kleeff J, Giese NA, Friess H, Bergmann F and Berger MR. Expression of HOXC8 is inversely related to the progression and metastasis of pancreatic ductal adenocarcinoma. Br J Cancer 2011; 105: 288-295.
46. Lopez R, Garrido E, Pina P, Hidalgo A, Lazos M, Ochoa R and Salcedo M. HOXB homeobox gene expression in cervical carcinoma. Int J Gynecol Cancer 2006; 16: 329-335.
47. Lopez R, Garrido E, Vazquez G, Pina P, Perez C, Alvarado I and Salcedo M. A subgroup of HOX Abd-B gene is differentially expressed in cervical cancer. Int J Gynecol Cancer 2006; 16: 1289-1296.
48. Alami Y, Castronovo V, Belotti D, Flagiello D and Clausse N. HOXC5 and HOXC8 expression are selectively turned on in human cervical cancer cells compared to normal keratinocytes. Biochem Biophys Res Commun 1999; 257: 738-745.
49. Hung YC, Ueda M, Terai Y, Kamagai K, Ueki K, Kanda K, Yamaguchi H, Akise D, Ueki M. Homeobox gene expression and mutation in cervical carcinoma cells. Cancer Scien 2003; 94: 437-441.